Simpson Interventions announced that it closed its Series C financing and rebranded to Elumn8 Medical. The Campbell, California–based company plans to use the undisclosed amount of proceeds raised in the Series C to support the continued development of its Acolyte image-guided crossing and re-entry catheter system. Acolyte aims to treat … [Read more...] about Simpson Interventions closes Series C, rebrands to Elumn8 Medical
Simpson Interventions
Simpson Interventions reports first patient treated with Acolyte catheter
Simpson Interventions announced today that investigators completed the first cases in a trial of its Acolyte catheter system. The Acolyte study, a pivotal investigational device exemption (IDE) trial, assesses the safety and effectiveness of the image-guided crossing and re-entry catheter system. It treats coronary chronic total occlusions (CTOs) … [Read more...] about Simpson Interventions reports first patient treated with Acolyte catheter
